TrialPediatric nephrology (Berlin, Germany)1996

Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.

P Tarshish et al.PubMed ↗Publisher ↗

No numbers read from the abstract.